Cardiovascular Diseases Clinical Trials in Atlanta, Georgia

8 studies are recruiting for cardiovascular diseases in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

   The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.

   Stage

   Not phased

   Ages

   18 to 100

   Site

   Piedmont Healthcare, Atlanta, Georgia

   Locations

   47 in total

   Run by

   BrioHealth Solutions, Inc.

   See if you can join NCT06310031 on ClinicalTrials.gov

2. Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

   PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the …

   Stage

   Phase 4

   Ages

   75 and older

   Site

   Atlanta VA Medical Center, Atlanta, Georgia

   Locations

   106 in total

   Run by

   Duke University

   See if you can join NCT04262206 on ClinicalTrials.gov

3. The Oxford Risk Factors And Non-Invasive Imaging Study

   ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.

   Stage

   Not phased

   Ages

   18 to 99

   Site

   Emory University, Atlanta, Georgia

   Locations

   45 in total

   Run by

   University of Oxford

   See if you can join NCT05169333 on ClinicalTrials.gov

4. The TRICURE EFS Study

   Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System

   Stage

   Not phased

   Ages

   18 and older

   Site

   Piedmont Healthcare Inc., Atlanta, Georgia

   Locations

   10 in total

   Run by

   TRiCares

   See if you can join NCT06506942 on ClinicalTrials.gov

5. SPYRAL GEMINI Pilot Study

   The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Piedmont Heart Institute, Atlanta, Georgia

   Locations

   18 in total

   Run by

   Medtronic Vascular

   See if you can join NCT06907147 on ClinicalTrials.gov

6. Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

   The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Piedmont Heart Institute, Atlanta, Georgia

   Locations

   68 in total

   Run by

   Abbott Medical Devices

   See if you can join NCT06526195 on ClinicalTrials.gov

7. MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

   This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Emory University Hospital /Emory School of Medice, Atlanta, Georgia

   Locations

   24 in total

   Run by

   Concept Medical Inc.

   See if you can join NCT06271590 on ClinicalTrials.gov

8. A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

   The is a first clinical study for Oricell Therapeutics Inc. in the United States to evaluate the safety, PK, PD and preliminary efficacy of our anti-GPRC5D cell product (OriCAR-017) in subjects with relapsed/refractory multiple myeloma. RIGEL Study

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Northside Hospital, Atlanta, Georgia

   Run by

   OriCell Therapeutics Co., Ltd.

   See if you can join NCT06271252 on ClinicalTrials.gov